AJANTAPHARMA / bear-case history

Track the concerns that keep returning.

Ajanta Pharma · risk themes across the available quarters.

Research layer active

Bear-case history

Risks carried through the record.

Middle East supply chain disruption

Geopolitical tensions have increased freight costs and transit times; if prolonged, could impact Asia business recovery and margins.

high

US FDA observations at Paithan plant

Five observations received; while management expects no immediate impact, any escalation could affect filings or existing product supplies.

medium

Price erosion in US generics and Africa institutional

Both markets are tender-driven and competitive; management factors erosion into guidance but unexpected acceleration could pressure margins.

medium

Promoter share pledging by non-executive brothers

Two promoter brothers have increased borrowing against shares for their own businesses, though no pledge on Ajanta shares; could raise governance concerns.

low